{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:39:25Z","timestamp":1787510365022,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["81800732"],"award-info":[{"award-number":["81800732"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["82073840"],"award-info":[{"award-number":["82073840"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M691957"],"award-info":[{"award-number":["2021M691957"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn201812016"],"award-info":[{"award-number":["tsqn201812016"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.coph.2022.102263","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:13:04Z","timestamp":1656997984000},"page":"102263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Novel strategies to promote resolution of inflammation to treat lower extremity artery disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen L.","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2169-2686","authenticated-orcid":false,"given":"Cheng Xue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2022.102263_bib1","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/CIRCRESAHA.116.303566","article-title":"Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease","volume":"116","author":"Hiatt","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2022.102263_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.RES.0000038961.53759.3C","article-title":"Development of the coronary vessel system","volume":"91","author":"Reese","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2022.102263_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1242\/dev.102.4.735","article-title":"Embryonic vascular development: immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos","volume":"102","author":"Coffin","year":"1988","journal-title":"Development"},{"key":"10.1016\/j.coph.2022.102263_bib4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jcmg.2018.08.039","article-title":"Histopathologic characterization of peripheral arteries in subjects with abundant risk factors: correlating imaging with pathology","volume":"12","author":"Torii","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.coph.2022.102263_sref5","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of peripheral artery disease in patients with critical limb ischemia","volume":"72","author":"Narula","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.coph.2022.102263_bib6","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/ATVBAHA.119.312864","article-title":"Pathologic disparities between peripheral artery disease and coronary artery disease","volume":"40","author":"Narula","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2022.102263_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2022.102263_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2022.102263_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrcardio.2011.66","article-title":"Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis","volume":"8","author":"Lau","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.coph.2022.102263_sref10","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1161\/CIRCRESAHA.121.318258","article-title":"Contemporary medical management of peripheral artery disease","volume":"128","author":"Bonaca","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2022.102263_bib11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41569-018-0005-0","article-title":"Interventions for lower extremity peripheral artery disease","volume":"15","author":"Hiramoto","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.coph.2022.102263_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1583\/13-4242.1","article-title":"Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis","volume":"20","author":"Indes","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.coph.2022.102263_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/cvr\/cvz214","article-title":"Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries?","volume":"116","author":"Spadaccio","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.coph.2022.102263_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coph.2022.102263_bib15","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.ATV.20.5.1177","article-title":"Natural history and histological classification of atherosclerotic lesions: an update","volume":"20","author":"Stary","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2022.102263_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7650260","article-title":"Cellular barriers after extravasation: leukocyte interactions with polarized epithelia in the inflamed tissue","volume":"2016","author":"Reglero-Real","year":"2016","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.coph.2022.102263_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0163-7258(02)00236-X","article-title":"LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis","volume":"95","author":"Chen","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2022.102263_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.coph.2022.102263_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2022.102263_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.coph.2022.102263_bib21","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2022.102263_bib22","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.amjcard.2011.01.007","article-title":"Relation of interleukin-6 and vascular cellular adhesion molecule-1 levels to functional decline in patients with lower extremity peripheral arterial disease","volume":"107","author":"McDermott","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.coph.2022.102263_bib23","first-page":"330","article-title":"Elabela as a novel marker: well-correlated with WIfI amputation risk score in lower extremity arterial disease patients","volume":"25","author":"Kaplan","year":"2021","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.coph.2022.102263_bib24","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/01.CIR.0000074227.53616.CC","article-title":"D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease","volume":"107","author":"McDermott","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2022.102263_bib25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.coph.2022.102263_sref26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acsptsci.9b00075","article-title":"New advances in targeting the resolution of inflammation: implications for specialized pro-resolving mediator GPCR drug discovery","volume":"3","author":"Park","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.coph.2022.102263_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.618653","article-title":"Pro-resolving mediator annexin A1 regulates intracellular Ca(2+) and mucin secretion in cultured goblet cells suggesting a new use in inflammatory conjunctival diseases","volume":"12","author":"Lyngstadaas","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2022.102263_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","article-title":"Resolution pharmacology: opportunities for therapeutic innovation in inflammation","volume":"36","author":"Perretti","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coph.2022.102263_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12016-020-08796-4","article-title":"Specialized pro-resolving lipid mediators: emerging therapeutic candidates for multiple sclerosis","volume":"60","author":"Zahoor","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.coph.2022.102263_sref30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","article-title":"Inflammation resolution: implications for atherosclerosis","volume":"130","author":"Doran","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2022.102263_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-019-0182-5","article-title":"Resolving atherosclerosis and Alzheimer disease","volume":"16","author":"Fredman","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.coph.2022.102263_bib32","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.it.2018.08.005","article-title":"Formyl-peptide receptors in infection, inflammation, and cancer","volume":"39","author":"Wei\u00df","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coph.2022.102263_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.118.039345","article-title":"Novel role for the AnxA1-fpr2\/ALX signaling Axis as a key regulator of platelet function to promote resolution of inflammation","volume":"140","author":"Senchenkova","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2022.102263_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.atherosclerosis.2018.09.025","article-title":"The atheroprotective role of lipoxin A(4) prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway","volume":"278","author":"Mai","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.coph.2022.102263_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2017.08.007","article-title":"Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease","volume":"125","author":"Bazan","year":"2017","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.coph.2022.102263_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/185715","article-title":"Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating I\u03baB\u03b1 signaling in human vascular endothelial cells","volume":"2013","author":"Zhang","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.coph.2022.102263_bib37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fimmu.2019.00571","article-title":"Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes","volume":"10","author":"Purvis","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2022.102263_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jss.2019.01.038","article-title":"Fish oil increases specialized pro-resolving lipid mediators in PAD (the OMEGA-PAD II trial)","volume":"238","author":"Ramirez","year":"2019","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.coph.2022.102263_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fphar.2019.00269","article-title":"Cardioprotective actions of the annexin-A1 N-terminal peptide, Ac(2-26), against myocardial infarction","volume":"10","author":"Qin","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2022.102263_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051188","article-title":"Annexin A1\/formyl peptide receptor pathway controls uterine receptivity to the blastocyst","volume":"9","author":"Hebeda","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.coph.2022.102263_bib41","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.4049\/jimmunol.0803175","article-title":"Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells","volume":"182","author":"Baker","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.coph.2022.102263_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCRESAHA.116.310308","article-title":"Anti-inflammatory effects of OxPAPC involve endothelial cell-mediated generation of LXA4","volume":"121","author":"Ke","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2022.102263_bib43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.intimp.2014.12.033","article-title":"Lipoxin A4 attenuates endothelial dysfunction during experimental cerebral malaria","volume":"24","author":"Souza","year":"2015","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.coph.2022.102263_bib44","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI97950","article-title":"The role of non-resolving inflammation in atherosclerosis","volume":"128","author":"Kasikara","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2022.102263_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/ATVBAHA.116.308744","article-title":"Protective aptitude of annexin A1 in arterial neointima formation in atherosclerosis-prone mice-brief report","volume":"37","author":"de Jong","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2022.102263_bib46","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/CIRCRESAHA.116.305825","article-title":"Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment","volume":"116","author":"Drechsler","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2022.102263_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16317-1","article-title":"Endogenous annexin-A1 regulates haematopoietic stem cell mobilisation and inflammatory response post myocardial infarction in mice in vivo","volume":"7","author":"Qin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2022.102263_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa1065","article-title":"Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice","volume":"7","author":"Fredman","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2022.102263_bib49","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1073\/pnas.1303377110","article-title":"Development and in\u00a0vivo efficacy of targeted polymeric inflammation-resolving nanoparticles","volume":"110","author":"Kamaly","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2022.102263_bib50","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2337\/db17-1317","article-title":"Lipoxins protect against inflammation in diabetes-associated atherosclerosis","volume":"67","author":"Brennan","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.coph.2022.102263_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbrc.2013.03.002","article-title":"Role of formyl peptide receptor 2 on the serum amyloid A-induced macrophage foam cell formation","volume":"433","author":"Lee","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2022.102263_bib52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijcard.2014.11.010","article-title":"Aspirin-triggered 15-epi-lipoxin A\u2084 signals through FPR2\/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation","volume":"179","author":"Petri","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.coph.2022.102263_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105699","article-title":"Dead cell and debris clearance in the atherosclerotic plaque: mechanisms and therapeutic opportunities to promote inflammation resolution","volume":"170","author":"Dhawan","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.coph.2022.102263_bib54","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/ATVBAHA.120.315758","article-title":"Resolvin D1 enhances necroptotic cell clearance through promoting macrophage fatty acid oxidation and oxidative phosphorylation","volume":"41","author":"Hosseini","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2022.102263_bib55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/2047487317694464","article-title":"Low salivary resolvin D1 to leukotriene B(4) ratio predicts carotid intima media thickness: a novel biomarker of non-resolving vascular inflammation","volume":"24","author":"Thul","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.coph.2022.102263_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142883","article-title":"The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection","volume":"131","author":"Arnardottir","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2022.102263_sref57","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.116.021894","article-title":"Resolvin D2 enhances postischemic revascularization while resolving inflammation","volume":"134","author":"Zhang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2022.102263_bib58","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/CIRCRESAHA.121.318266","article-title":"New directions in therapeutic angiogenesis and arteriogenesis in peripheral arterial disease","volume":"128","author":"Annex","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2022.102263_bib59","doi-asserted-by":"crossref","first-page":"30541","DOI":"10.1074\/jbc.M112.393561","article-title":"Annexin-1-mediated endothelial cell migration and angiogenesis are regulated by vascular endothelial growth factor (VEGF)-induced inhibition of miR-196a expression","volume":"287","author":"Pin","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2022.102263_bib60","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3389\/fphar.2018.01015","article-title":"Annexin A1(2-26) treatment improves skin heterologous transplantation by modulating inflammation and angiogenesis processes","volume":"9","author":"Lacerda","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2022.102263_bib61","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1172\/JCI124616","article-title":"More friend than foe: the emerging role of neutrophils in tissue repair","volume":"129","author":"Peiseler","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2022.102263_bib62","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.jacc.2019.03.503","article-title":"Pro-angiogenic macrophage phenotype to promote myocardial repair","volume":"73","author":"Ferraro","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.coph.2022.102263_bib63","first-page":"187","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2022.102263_bib64","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1073\/pnas.1918163117","article-title":"Myeloid ALX\/FPR2 regulates vascularization following tissue injury","volume":"117","author":"Sansbury","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2022.102263_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba7702","article-title":"Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy","volume":"6","author":"Turner","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.coph.2022.102263_bib66","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/stem.1578","article-title":"WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells","volume":"32","author":"Heo","year":"2014","journal-title":"Stem Cell"},{"key":"10.1016\/j.coph.2022.102263_bib67","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/sctm.20-0141","article-title":"Human endothelial colony-forming cells in regenerative therapy: a systematic review of controlled preclinical animal studies","volume":"9","author":"Liao","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.coph.2022.102263_bib68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.coph.2022.102263_sref69","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14232","article-title":"Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice","volume":"8","author":"Qin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2022.102263_bib70","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41467-017-02656-0","article-title":"Correspondence: reply to 'Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury'","volume":"9","author":"Qin","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2022.102263_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041384","article-title":"The novel small-molecule annexin-A1 mimetic, compound 17b, elicits vasoprotective actions in streptozotocin-induced diabetic mice","volume":"21","author":"Marshall","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2022.102263_bib72","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2174\/0929867321666131218095521","article-title":"Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition","volume":"21","author":"Schepetkin","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.coph.2022.102263_sref73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113167","article-title":"Recent advances in the design and development of formyl peptide receptor 2 (FPR2\/ALX) agonists as pro-resolving agents with diverse therapeutic potential","volume":"213","author":"Maciuszek","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.coph.2022.102263_bib74","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","article-title":"Mechanisms of signalling and biased agonism in G protein-coupled receptors","volume":"19","author":"Wootten","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.coph.2022.102263_bib75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pharmthera.2010.04.010","article-title":"Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists","volume":"127","author":"Dufton","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2022.102263_bib76","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.1021\/acs.jmedchem.9b02101","article-title":"Discovery of BMS-986235\/LAR-1219: a potent formyl peptide receptor 2 (FPR2) selective agonist for the prevention of heart failure","volume":"63","author":"Asahina","year":"2020","journal-title":"J\u00a0Med Chem"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148922200090X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148922200090X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:57:43Z","timestamp":1761461863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147148922200090X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":76,"alternative-id":["S147148922200090X"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2022.102263","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel strategies to promote resolution of inflammation to treat lower extremity artery disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2022.102263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102263"}}